Mackenzie Financial’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Buy
1,642,626
+1,045,184
+175% +$3.95M 0.01% 725
2026
Q1
$1.73M Buy
597,442
+389,563
+187% +$831K ﹤0.01% 965
2025
Q4
$324K Buy
+207,879
New +$327K ﹤0.01% 1351
2022
Q4
Sell
-10,757
Closed -$37K 1531
2022
Q3
$37K Sell
10,757
-1,909
-15% -$7.3K ﹤0.01% 1381
2022
Q2
$37K Buy
+12,666
New +$66.6K ﹤0.01% 1412

Other funds holding MGNX

Mackenzie Financial's MGNX Position: Q2 2026 in Review

Mackenzie Financial increased its MacroGenics (MGNX) stake by 175% in Q2 2026, buying an estimated $3.95M and bringing the position to 1,642,626 shares worth $7.59M. The position accounts for 0.01% of the portfolio, ranked #725.

Mackenzie Financial first reported a position in MGNX in Q2 2022 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Mackenzie Financial held 1,642,626 shares of MacroGenics worth $7.59M as of Q2 2026.
  • Mackenzie Financial bought 1,045,184 MacroGenics shares in Q2 2026, an estimated $3.95M.
  • MacroGenics made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #725 holding.
  • Mackenzie Financial first reported a position in MacroGenics in Q2 2022 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.